Offering includes 5 million shares with a $10.5 million greenshoe
By Devika Patel
Knoxville, Tenn., June 26 - Esperion Therapeutics, Inc. priced its $70 million initial public offering of stock with a $10.5 million greenshoe, according to a free-writing prospectus filed Wednesday with the Securities and Exchange Commission. It expects the shares to trade on the Nasdaq Global Market under the symbol "ESPR."
The company will sell 5 million common shares at $14.00 per share.
The deal is being conducted by joint bookrunning managers Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc.
The clinical-stage biopharmaceutical company is based in Plymouth, Mich.
| Issuer: | Esperion Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $70 million
|
| Greenshoe: | $10.5 million
|
| Shares: | 5 million
|
| Price: | $14.00
|
| Warrants: | No
|
| Bookrunners: | Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc.
|
| Co-managers: | JMP Securities LLC and Stifel, Nicolaus & Co., Inc.
|
| Pricing date: | June 26
|
| Stock exchange: | Nasdaq: ESPR
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
